🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Endurance Trial is a phase IV open label clinical study to assess the n...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02297204
Treatments Being Tested
The purpose of this clinical study is to evaluate the efficacy and safety o...
Status
Terminated
Location
Kanghong Investigative Site
Start Date
2018-09-25
Trial ID
NCT03577899
This study is designed to compare the post injection inflammation and pain ...
Status
Completed
Location
Sierra Eye Associates
Start Date
2015-01
Trial ID
NCT02363621
Treatments Being Tested
Phase 1, non-randomized, open label, noncomparative trial to study the effe...
Status
Unknown
Location
Illinois Retina and Eye Associates
Start Date
2015-05-14
Trial ID
NCT02403128
Treatments Being Tested
This is a phase 3 randomized, double -masked study comparing the efficacy o...
Status
Recruiting
Location
California Retina Consultants
Start Date
2026-02-16
Trial ID
NCT07449936
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of intravitr...
Status
Completed
Location
The Retina Institute
Start Date
2012-06
Trial ID
NCT01578720
Treatments Being Tested
This study will assess the efficacy and safety of intravitreally (IVT), i.e...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01482910
Treatments Being Tested
This is a phase 3 randomized, double -masked study comparing the efficacy o...
Status
Active Not Recruiting
Location
Associated Retina Consultans
Start Date
2024-11-27
Trial ID
NCT06683742
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of RC28-E comp...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-06-08
Trial ID
NCT05885503
Treatments Being Tested
This is an open label study to evaluate intravitreally administered 2.0 mg ...
Status
Completed
Location
Vitreous Retina Macula Consultants of New York
Start Date
2011-12
Trial ID
NCT01495221
Treatments Being Tested